Tammam Hanna, MD, an orthopedic surgeon in Lubbock, Texas, performed the first U.S. clinical case of TYBR Health’s B3 Gel system, according to a Jan. 5 news release.
B3 Gel is a collagen-based tissue protector derived from extracellular matrix and conforms to the tissue surface.
“In a complex second-stage flexor tendon reconstruction—where balancing tissue protection with early rehabilitation is critical — I applied B3 GEL directly over the repair,” Dr. Hanna said in the release. “The gel set within minutes, maintained excellent visualization, and allowed smooth tendon gliding without restricting motion. I subsequently used it in two additional flexor tendon repair cases, and across these early cases I observed consistently favorable early range of motion, minimal stiffness, and no complications — findings that are very encouraging in this patient population.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
